SCHEMBL4401845

SCHEMBL4401845

NCc1cccc(C2(O)CCN(C(=O)c3cncc(CCc4ccccc4)c3)CC2)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.51
LMNA P02545 2/20 0.51
CYP3A4 P08684 2/20 0.48
CYP2C19 P33261 2/20 0.48
CYP2C9 P11712 1/20 0.48
PARP10 Q53GL7 1/20 0.46
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
CA12 O43570 1/20 0.45
CA1 P00915 1/20 0.45
CA2 P00918 1/20 0.45
CA7 P43166 1/20 0.45
CA9 Q16790 1/20 0.45
CA14 Q9ULX7 1/20 0.45
CHRM2 P08172 1/20 0.44
PRSS1 P07477 1/20 0.42
PRSS2 P07478 1/20 0.42
PRSS3 P35030 1/20 0.42
KDM4E B2RXH2 1/20 0.41
ALOX15 P16050 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL1380703 0.95 LMNA (0.47) ALDH1A1LMNACYP3A4CYP2C19CYP2C9
SCHEMBL4395821 0.88 CA12 (0.48) ALDH1A1LMNAPARP10CA12CA1
SCHEMBL4406054 0.84 LMNA (0.43) ALDH1A1LMNACYP3A4CYP2C19CYP2C9
SCHEMBL7021172 0.80 TPSAB1 (0.53)
Hydrochloric Acid SCHEMBL4402047 0.79 TPSAB1 (0.52)
SCHEMBL4407004 0.77 MEN1 (0.47) ALDH1A1LMNACYP3A4CYP2C19CYP2C9
SCHEMBL9011197 0.77 ALDH1A1 (0.65) ALDH1A1LMNACYP3A4CYP2C19CYP2C9
SCHEMBL7027368 0.76 TPSAB1 (0.45) ALDH1A1MEN1KMT2ACA12CA1
SCHEMBL1384618 0.76 F11 (0.44) CA12CA1CA2CA7CA9
Hydrochloric Acid SCHEMBL4395982 0.76 TPSAB1 (0.44) ALDH1A1MEN1KMT2ACA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1296972-B1 ARYLMETHYLAMINE DERIVATIVES FOR USE AS TRYPTASE INHIBITORS AVENTIS PHARMA INC (US) 2009-12-23 EP claimed
US-6977263-B2 Chemical compounds AVENTIS PHARMACEUTICALS INC. (US) 2005-12-20 US disclosed